Novel anticancer agents for multiple myeloma: a review of the evidence for their therapeutic and economic value.
about
Novel agents for multiple myeloma to overcome resistance in phase III clinical trialsDiagnostic and therapeutic approaches to multiple myeloma patients: 'Real-world' data from representative multicentre treatment surveys in Germany between 2008 and 2011.Efficient allocation of novel agents in multiple myeloma: a work in progressEconomic evaluation of therapies for patients suffering from relapsed-refractory multiple myeloma in Greece.Engineered T cells: the promise and challenges of cancer immunotherapy.A cost-effectiveness analysis of real-world treatment for elderly patients with multiple myeloma using a full disease model.
P2860
Novel anticancer agents for multiple myeloma: a review of the evidence for their therapeutic and economic value.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Novel anticancer agents for mu ...... herapeutic and economic value.
@en
type
label
Novel anticancer agents for mu ...... herapeutic and economic value.
@en
prefLabel
Novel anticancer agents for mu ...... herapeutic and economic value.
@en
P2093
P2860
P356
P1476
Novel anticancer agents for mu ...... herapeutic and economic value.
@en
P2093
Carin A Uyl-de Groot
Jennifer G Gaultney
William K Redekop
P2860
P304
P356
10.1586/ERA.12.42
P577
2012-06-01T00:00:00Z